Topamax
- Product NDC
- 70518-2753
- 11-digit product format
- 705182753
- Labeler code
- 70518
- Product ID
- 70518-2753_dca34fa4-e59a-3f2a-e053-2a95a90a1651
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- topiramate
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- NDA020505
- Marketing category
- NDA
- Marketing start
- 2020-05-26
- Marketing end
- 0000-00-00
- Substance
- TOPIRAMATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2753-0 | 70518275300 | 30 TABLET, COATED in 1 BLISTER PACK (70518-2753-0) | 2020-05-26 | 0000-00-00 | No | No | Current |